Conference abstractPublished 28 Jan 2019
Astaxanthin: A new way to fight against Alzheimer’s disease
Ari Healthcare Pvt. Ltd., India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Even though the precise molecular mechanisms responsible for aging of the brain cells at the end of the day landed upon significant alterations in some cognitive domains and neurodegenerative diseases are still being unexplained. Astaxanthin is a reddish pigment that belongs to a group of compounds called as carotenoids. It occurs naturally in some algae and causes the pink or red color in salmon, trout, lobster, shrimp and other seafood. This compound dramatically grabs the popularity since last few decades and many researchers are loved to study the molecule for the Alzheimer’s and other related neurodegeneration. Results from the many research studies are reported and suggest a neuroprotective property which covers anti-inflammatory, anti-apoptotic and anti-oxidant effects as well as the prospective action to support neural plasticity. These promising mechanisms of actions involve Astaxanthin as a promising therapeutic agent in the treatment of neurodegenerative disease. It is believed that nutritional supplementation of Astaxanthin for 12 weeks improved psychomotor speed and processing speed, as measured by the CNSVS test, which is related to the ability to comprehend, and accomplish multifarious tasks rapidly and precisely. Research studies have also confirmed that Astaxanthin can easily cross the blood-brain barrier to safeguard the brain from acute injury and chronic neurodegeneration. Astaxanthin is an outstanding candidate for managing neurological diseases. It is necessary to continue further assessments through all facets of Astaxanthin’s protective action and essential mechanisms, which may ultimately result to get Astaxanthin as a novel neuroprotective agent in the treatment of Alzheimer’s dementia.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Dheeraj Nagore”